Schubert & Co’s Synovus SNV Stock Holding History

Schubert & Co’s Portfolio SNV Stock Details SNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-45	Closed	-$1.39K	–	1294
2023 Q1	$1.39K	Sell	45 -10	-18%	-$381	﹤0.01%	1059
2022 Q4	$2.06K	Sell	55 -21	-28%	-$834	﹤0.01%	858
2022 Q3	$3K	Buy	76 +24	+46%	+$952	﹤0.01%	673
2022 Q2	$2K	Buy	52 +23	+79%	+$952	﹤0.01%	879
2022 Q1	$1K	Buy	29 +6	+26%	+$304	﹤0.01%	912
2021 Q4	$1K	Buy	+23	New	+$1.09K	﹤0.01%	858

Other funds holding SNV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Schubert & Co's SNV Position: Q2 2023 in Review

Schubert & Co sold out of Synovus (SNV) in Q2 2023, closing a stake of 45 shares — an estimated $1.39K sold.

Schubert & Co first reported a position in SNV in Q4 2021 and held it in 6 quarters. The position peaked at $3K in Q3 2022. 370 funds tracked by Wall St. Rank hold SNV as of Q2 2023.

Schubert & Co reported no remaining Synovus position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 45 Synovus shares in Q2 2023, an estimated $1.39K.
Schubert & Co first reported a position in Synovus in Q4 2021 and held it in 6 quarters.
Schubert & Co's Synovus position peaked at $3K in Q3 2022.
370 funds tracked by Wall St. Rank held Synovus as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.